CTRI/2018/09/015693尚未招募4 期
Real world experience of Glycomet GP (Glimepiride/Metformin) in management of Type 2 Diabetes mellitus in Indian Setting (REAL GGP) - USV/REALGGP/01
SV Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Both Male and Female patients of age 18 years or older
- •Patients who have received any strength of Glycomet GP (Glimepiride/Metformin) for the treatment of type 2 diabetes mellitus
- •Treating physician had to agree to provide information regarding the participants treatment
- •Patients whose medical records contains a minimum core data set; core data defined as: age, gender, duration of diabetes/ age at diagnosis, all glucose-lowering medications (branded and generic names, dosage and dosing frequency).
排除标准
- •Patients with Type 1 diabetes mellitus
- •Patients with cancer, end stage liver disease, end stage renal failure (non-diabetes related)
- •Female patients with gestational diabetes during pregnancy
研究者
相似试验
已完成
不适用
A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19CTRI/2020/07/026353Bansi Gir Gaushala34
已完成
4 期
Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 DiabetesType 2 Diabetes MellitusNCT06759922Bahria University172
已完成
不适用
Voglibose v/s Glimepiride Efficacy and Safety in Combination with Metformin in Type-2 Diabetes Mellitus patientsCTRI/2021/04/033005AIIMS JODHPUR73
已完成
3 期
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsDiabetes Mellitus, Type 2NCT01459809Sanofi538
已完成
4 期
Assessment of Glycopyrrolate in patients with breathing problems.CTRI/2018/04/012944Glenmark Pharmaceuticals Ltd1,215